tocophersolan has been researched along with galactose in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 5 (55.56) | 2.80 |
Authors | Studies |
---|---|
Cheng, H; Guo, H; Li, C; Liu, G; Liu, X; Wang, Y; Zhang, F; Zhang, Y; Zhao, Z | 1 |
Dong, H; Gao, M; Li, Q; Pang, Y; Tian, Y; Wang, J; Wu, G; Xu, H; Zhang, B; Zhang, C; Zhang, H | 1 |
Kurmi, BD; Paliwal, R; Paliwal, SR; Tekchandani, P | 1 |
Du, Z; Fu, J; Hu, J; Mao, Y; Yin, J; You, Q; Zhang, P | 1 |
Brueggemeier, RW; Kanthamneni, N; Lee, LJ; Lee, RJ; Mao, Y; Sugimoto, Y; Yu, B; Zhang, Y; Zhou, C | 1 |
McKelvey, C; Moser, J; Rege, B; Sotthivirat, S; Xu, W; Zhang, D | 1 |
Abd-Elsalam, WH; Ibrahim, RR | 1 |
da Silva Neto, MR; de Gomes, MG; de Oliveira Pacheco, C; Dos Santos, RB; Giacomeli, R; Haas, SE; Maciel, TR; Parisotto, AJM; Ribeiro, ACF | 1 |
Indulkar, AS; Lou, X; Taylor, LS; Zhang, GGZ | 1 |
9 other study(ies) available for tocophersolan and galactose
Article | Year |
---|---|
Novel galactosylated biodegradable nanoparticles for hepatocyte-delivery of oridonin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Diterpenes, Kaurane; Drug Carriers; Drug Liberation; Galactose; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2016 |
N-acetylaminogalactosyl-decorated biodegradable PLGA-TPGS copolymer nanoparticles containing emodin for the active targeting therapy of liver cancer.
Topics: Apoptosis; Biological Transport; Drug Carriers; Emodin; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Molecular Targeted Therapy; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2018 |
Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Drug Development; Female; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; Male; Random Allocation; Rats; Tissue Distribution; Vitamin E | 2020 |
TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Drug Therapy; Galactose; Humans; Indoles; Infrared Rays; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nitric Oxide Donors; Nitroso Compounds; Photothermal Therapy; Polymers; Rats, Sprague-Dawley; Vitamin E; Xenograft Model Antitumor Assays | 2021 |
SPANosomes as delivery vehicles for small interfering RNA (siRNA).
Topics: Aromatase; Cell Line, Tumor; Cryoelectron Microscopy; Fatty Acids, Monounsaturated; Flow Cytometry; Gene Knockdown Techniques; Green Fluorescent Proteins; Hexoses; Humans; Liposomes; Microscopy, Electron, Transmission; Nanoparticles; Oligonucleotide Probes; Particle Size; Polyethylene Glycols; Quaternary Ammonium Compounds; RNA, Small Interfering; Surface-Active Agents; Transfection; Vitamin E | 2012 |
Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
Topics: Amides; Animals; Cannabinoid Receptor Agonists; Excipients; Hexoses; Macaca mulatta; Methylcellulose; Polyethylene Glycols; Polysorbates; Pyridines; Pyrrolidines; Solubility; Surface-Active Agents; Vinyl Compounds; Vitamin E; Water | 2013 |
Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections.
Topics: Acyclovir; Chitosan; Drug Carriers; Drug Delivery Systems; Hexoses; Lipids; Nanoparticles; Particle Size; Vitamin E | 2021 |
Surface-functionalized curcumin-loaded polymeric nanocapsules could block apomorphine-induced behavioral changes in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Curcumin; Dopamine Agonists; Enzyme Inhibitors; Hexoses; Nanocapsules; Plants, Medicinal; Rats; Stereotyped Behavior; Treatment Outcome; Vitamin E | 2022 |
Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
Topics: Drug Compounding; Drug Liberation; Hexoses; HIV Protease Inhibitors; Kinetics; Polysorbates; Pyrrolidines; Ritonavir; Solubility; Surface-Active Agents; Vinyl Compounds; Vitamin E | 2022 |